Facticin 320 mg

Facticin, with the active ingredient Gemifloxacin, is a broad-spectrum fluoroquinolone antibiotic designed to combat a variety of bacterial infections. It is particularly effective against respiratory tract infections, including acute bacterial exacerbation of chronic bronchitis (ABECB) and community-acquired pneumonia (CAP) caused by susceptible bacteria.

Facticin works by inhibiting bacterial enzymes, DNA gyrase, and topoisomerase IV, which are essential for bacterial DNA replication, transcription, repair, and recombination. This dual mechanism of action ensures a high efficacy against both Gram-positive and Gram-negative pathogens.

Key Features:

• Active Ingredient: Gemifloxacin Mesylate
• Dosage Strength: 320 mg tablets
• Mechanism of Action: Inhibits bacterial DNA gyrase and topoisomerase IV, halting bacterial growth and proliferation.
• Spectrum of Activity: Effective against common respiratory pathogens, including Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis, as well as atypical organisms like Mycoplasma pneumoniae and Chlamydophila pneumoniae.

Indications:
Facticin is prescribed for the treatment of:

1. Acute bacterial exacerbation of chronic bronchitis (ABECB)
2. Community-acquired pneumonia (CAP)

Dosage and Administration:
The recommended dosage is one 320 mg tablet taken orally once daily, with or without food. Treatment duration varies depending on the severity of the infection and the pathogen involved.

Precautions:

• Use with caution in patients with a history of tendon disorders or those taking corticosteroids.
• Avoid in individuals with known hypersensitivity to fluoroquinolones.
• Not recommended for use in children, pregnant, or breastfeeding women unless deemed necessary.

Storage:
Store at room temperature, away from direct sunlight and moisture.

Facticin is a trusted solution for bacterial infections, offering rapid symptom relief and promoting recovery. Always consult a healthcare professional for proper diagnosis and treatment